Japan Tissue Engineering Future Growth
Future criteria checks 5/6
Japan Tissue Engineering is forecast to grow earnings and revenue by 219.4% and 50% per annum respectively while EPS is expected to grow by 219.7% per annum.
Key information
219.4%
Earnings growth rate
219.7%
EPS growth rate
Biotechs earnings growth | 31.0% |
Revenue growth rate | 50.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 Jan 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2025 | 4,393 | 959 | N/A | N/A | 1 |
3/31/2024 | 2,832 | 95 | N/A | N/A | 1 |
12/31/2023 | 2,374 | -157 | N/A | N/A | N/A |
9/30/2023 | 2,306 | -319 | -291 | -139 | N/A |
6/30/2023 | 2,272 | -448 | N/A | N/A | N/A |
3/31/2023 | 2,032 | -729 | -797 | -622 | N/A |
12/31/2022 | 1,951 | -782 | N/A | N/A | N/A |
9/30/2022 | 2,095 | -651 | -668 | -468 | N/A |
6/30/2022 | 2,047 | -636 | N/A | N/A | N/A |
3/31/2022 | 2,103 | -497 | -342 | -225 | N/A |
12/31/2021 | 2,469 | -396 | N/A | N/A | N/A |
9/30/2021 | 2,321 | -461 | -342 | -275 | N/A |
6/30/2021 | 2,358 | -421 | N/A | N/A | N/A |
3/31/2021 | 2,257 | -466 | -473 | -399 | N/A |
12/31/2020 | 2,187 | -335 | N/A | N/A | N/A |
9/30/2020 | 2,242 | -288 | -299 | -229 | N/A |
6/30/2020 | 2,253 | -277 | N/A | N/A | N/A |
3/31/2020 | 2,309 | -287 | -175 | -84 | N/A |
12/31/2019 | 2,325 | -210 | N/A | N/A | N/A |
9/30/2019 | 2,317 | -189 | -211 | -77 | N/A |
6/30/2019 | 2,366 | -77 | N/A | N/A | N/A |
3/31/2019 | 2,357 | -333 | -468 | -396 | N/A |
12/31/2018 | 2,199 | -364 | N/A | N/A | N/A |
9/30/2018 | 2,204 | -255 | -212 | -184 | N/A |
6/30/2018 | 2,188 | -216 | N/A | N/A | N/A |
3/31/2018 | 2,271 | 227 | 601 | 632 | N/A |
12/31/2017 | 2,590 | 585 | N/A | N/A | N/A |
9/30/2017 | 2,459 | 507 | N/A | 544 | N/A |
6/30/2017 | 2,282 | 401 | N/A | N/A | N/A |
3/31/2017 | 2,135 | 276 | N/A | 54 | N/A |
12/31/2016 | 1,628 | -165 | N/A | N/A | N/A |
9/30/2016 | 1,500 | -405 | N/A | -314 | N/A |
6/30/2016 | 1,470 | -567 | N/A | N/A | N/A |
3/31/2016 | 1,430 | -681 | N/A | -346 | N/A |
12/31/2015 | 1,431 | -651 | N/A | N/A | N/A |
9/30/2015 | 1,503 | -600 | N/A | -587 | N/A |
6/30/2015 | 1,343 | -713 | N/A | N/A | N/A |
3/31/2015 | 1,321 | -690 | N/A | -756 | N/A |
12/31/2014 | 1,177 | -833 | N/A | N/A | N/A |
9/30/2014 | 1,103 | -861 | N/A | -755 | N/A |
6/30/2014 | 1,083 | -815 | N/A | N/A | N/A |
3/31/2014 | 1,008 | -827 | N/A | -961 | N/A |
12/31/2013 | 847 | -996 | N/A | N/A | N/A |
9/30/2013 | 740 | -1,022 | N/A | -918 | N/A |
6/30/2013 | 692 | -996 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7774 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: 7774 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 7774 is expected to become profitable in the next 3 years.
Revenue vs Market: 7774's revenue (50% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 7774's revenue (50% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 7774's Return on Equity is forecast to be high in 3 years time